Search - tctmd.com

Displaying 501 - 520 of 545

Sort: Relevancy | Date

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Daily News

CLOSURE I Published as Similar PFO Trials Forge Ahead

Caitlin E. Cox

March 15, 2012

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

Presentation

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Presenter: Hans-Christoph Diener

March 08, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Daily News

PFO Closure Can Prevent Recurrent Cerebrovascular Events

Yael L. Maxwell

March 06, 2012

News Daily News

PCI-Related Stroke Rare, Tied to Modifiable Procedural Factors

Yael L. Maxwell

March 06, 2012

News Daily News

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

March 06, 2012

News Daily News

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

L.A. McKeown

March 06, 2012

News Daily News

Documento Examina las Diferencias que existen entre Estudios Observacionales y Aleatorizados del Cierre del PFO

L.A. McKeown

March 06, 2012

News Daily News

Cerebrovascular Event Risk Highest in First 24 Hours After TAVR

March 06, 2012

News Daily News

CAS Plus Cardiac Surgery a Promising Option for Symptomatic Patients

Yael L. Maxwell

December 07, 2011

News Conference News

Embolic Protection Devices for TAVR Show Promise

November 09, 2011

News Industry News

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

November 09, 2011

News Industry News

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

November 09, 2011

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

News Daily News

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Jason Kahn

November 06, 2011

News Conference News

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

November 06, 2011

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

Advertisement

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

CLOSURE I Published as Similar PFO Trials Forge Ahead

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

Experts Give Their Picks for Most Important Developments of 2011

Apixaban vs. Aspirin in Patients with A-fib and Previous Stroke or TIA

Societies Recommend TAVR Program Requirements

PFO Closure Can Prevent Recurrent Cerebrovascular Events

PCI-Related Stroke Rare, Tied to Modifiable Procedural Factors

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

Documento Examina las Diferencias que existen entre Estudios Observacionales y Aleatorizados del Cierre del PFO

Cerebrovascular Event Risk Highest in First 24 Hours After TAVR

CAS Plus Cardiac Surgery a Promising Option for Symptomatic Patients

Embolic Protection Devices for TAVR Show Promise

Two-year study of transcatheter aortic valve replacement demonstrates continued superiority over standard therapy

TAVI at TCT: Enthusiasm Tempered by Poor Transapical Outcomes

Caution Urged in Widespread Adoption of TAVR

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

Virmani's crystal ball: Transcatheter valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content